ANVISA registration 80048490106Valid until Jan 05, 2036PROSTATE-SPECIFIC ANTIGEN (PSA)
ANVISA Registration Number: 80048490106USA DIAGNOSTICA LTDAMONOBIND, INCRisk Class III
Device names
- Technical name
- PROSTATE-SPECIFIC ANTIGEN (PSA)
- Risk class
- Class III
PT: ANTÍGENO PROSTÁTICO ESPECÍFICO (PSA)
Registration details
- Registration Number
- 80048490106
- Process Number
- 25351108656202587
- CNPJ
- 02330159000108
Company information
- Registration Holder
- USA DIAGNOSTICA LTDA
- Manufacturer
- MONOBIND, INC
- Manufacturing Country
- United States
PT: ESTADOS UNIDOS DA AMÉRICA
Dates and status
- Publication Date
- Jan 05, 2026
- Validity
- 05/01/2036
- Last Updated
- 08/18/2026 19:00:00
About this record
Access comprehensive regulatory information for PROSTATE-SPECIFIC ANTIGEN (PSA) in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 80048490106 and manufactured by MONOBIND, INC. The registration is held by USA DIAGNOSTICA LTDA with validity until Jan 05, 2036.
This page shows the facts attached to this official registry row. Exact-name links return deterministic registry matches; open-ended comparison and market analysis are handed to AI Search with this record's context, without asserting that similar names represent the same entity.